Loading...
HSChapter 30
U.S. imports of cardiovascular medicaments, containing hydralazine or its salts, put up in measured doses or in forms for retail sale (HS 3004909220) totaled $9.6M in June 2026, traded with 14 countries.
Importers of Cardiovascular Medicaments, Containing Hydralazine or Its Salts, Put Up in Measured Doses or in Forms for Retail Sale paid $45K in duties in June 2026 — an effective duty rate of 10% on $447K in dutiable value, based on actual customs collections rather than the published tariff schedule. Cardiovascular Medicaments, Containing Hydralazine or Its Salts, Put Up in Measured Doses or in Forms for Retail Sale imports of $9.6M in June 2026 ran 49% above the year-to-date monthly average of $6.5M.
Supplier Network
Get discovered by U.S. importers searching for HS 3004909220 — Cardiovascular Medicaments, Containing Hydralazine or Its Salts, Put Up in Measured Doses or in Forms for Retail Sale. Be the first supplier listed.
Monthly import values over time
No geographic breakdown available
U.S. trade for this product is not broken down by state or port in the latest Census Bureau release.
| Country | Imports | Exports | Balance |
|---|---|---|---|
| INDIA | $8.3M | -- | -$8.3M |
| GERMANY | $447K | -- | -$447K |
| CZECH REPUBLIC | $309K | -- | -$309K |
| CANADA | $250K | -- | -$250K |
| BANGLADESH | $184K | -- | -$184K |